Cargando…
Established and Emerging Biomarkers in Cutaneous Malignant Melanoma
In an era of personalized medicine, disease specific biomarkers play an increasing role in the stratification of high-risk patient groups. Cutaneous malignant melanoma is the most deadly form of skin cancer with an ever-increasing global incidence, especially in patients under 35-years of age. Despi...
Autores principales: | Verykiou, Stamatina, Ellis, Robert A, Lovat, Penny E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4934494/ https://www.ncbi.nlm.nih.gov/pubmed/27429260 http://dx.doi.org/10.3390/healthcare2010060 |
Ejemplares similares
-
Prognostic Impact of Autophagy Biomarkers for Cutaneous Melanoma
por: Tang, Diana Y. L., et al.
Publicado: (2016) -
Prognostic impact of p62 expression in cutaneous malignant melanoma
por: Ellis, Robert A, et al.
Publicado: (2013) -
Harnessing autophagy to overcome mitogen‐activated protein kinase kinase inhibitor‐induced resistance in metastatic melanoma
por: Verykiou, S., et al.
Publicado: (2018) -
Cutaneous malignant melanoma in Scotland.
por: MacKie, R. M., et al.
Publicado: (1982) -
Cutavirus in Cutaneous Malignant Melanoma
por: Mollerup, Sarah, et al.
Publicado: (2017)